Home › Partnership over acquisition: Could the Juno-Celgene deal be the new norm for biotech?
 

Keywords :   


Partnership over acquisition: Could the Juno-Celgene deal be the new norm for biotech?

2015-07-15 10:44:11| Biotech - Topix.net

When Seattle biotech Juno Therapeutics announced a history-making deal with New Jersey-based Celgene Corp. at the end of June, analysts had mixed reactions.

Tags: the for deal partnership

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »